Showing results (251-260 of 300) with videos related to
Sort By:
Pageof 30
European Journal of Clinical Investigation|October 1, 1989
Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approachJ H Schellens, A R Janssens, J H van der Wart, et al.Biochemical Pharmacology|July 17, 1995
High-density lipoprotein and cerebral endothelial cells in vitro: interactions and transportH E de Vries, B Breedveld, J Kuiper, et al.British Journal of Clinical Pharmacology|November 1, 1984
Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosisM W Teunissen, P Spoelstra, C W Koch, et al.British Journal of Pharmacology|November 1, 1995
Application of intracerebral microdialysis to study regional distribution kinetics of drugs in rat brainE C de Lange, M R Bouw, J W Mandema, et al.Clinical Pharmacology and Therapeutics|November 1, 1991
Differential effects of quinidine on the disposition of nifedipine, sparteine, and mephenytoin in humansJ H Schellens, H Ghabrial, H H van der Wart, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1986
Biotransformation of 1,2-dibromopropane in rats into four mercapturic acid derivativesC E Zoetemelk, I H Oei, B van Meeteren-Wälchli, et al.Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1989
The unit impulse response procedure for the pharmacokinetic evaluation of drug entry into the central nervous systemJ B van Bree, A V Baljet, A van Geyt, et al.Pharmaceutical Research|December 1, 1995
The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brainE C de Lange, J D de Vries, C Zurcher, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Effect of anisotonic conditions on the transport of hydrophilic model compounds across monolayers of human colonic cell linesA B Noach, M Sakai, M C Blom-Roosemalen, et al.The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the ratR A Mathôt, E A van Schaick, M W Langemeijer, et al.Pageof 30